Richard Kwizera

Dr. Richard Kwizera

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Emerging Infectious Diseases
Verified
Journal Article
Open access
DBDavid Boulware
David Boulware
MRMelissa A. Rolfes
Melissa A. Rolfes
RRRadha Rajasingham
Radha Rajasingham
MHMaximilian von Hohenberg
Maximilian von Hohenberg
ZQZhenpeng Qin
Zhenpeng Qin
DMDavid B. Meya
David B. Meya
Cryptococcal meningitis is common in sub-Saharan Africa. Given the need for data for a rapid, point-of-care cryptococcal antigen (CRAG) lateral flow immunochromatographic assay (LFA), we assessed diagnostic performance of cerebrospinal fluid (CSF) culture, CRAG latex agglutination, India ink microscopy, and CRAG LFA for 832 HIV-infected persons with suspected meningitis during 2006–2009 (n = 299) in Uganda and during 2010–2012 (n = 533) in Uganda and South Africa. CRAG LFA had the best performance (sensitivity 99.3%, specificity 99.1%). Culture sensitivity was dependent on CSF volume (82.4% for 10 μL, 94.2% for 100 μL). CRAG latex agglutination test sensitivity (97.0%–97.8%) and specificity (85.9%–100%) varied between manufacturers. India ink microscopy was 86% sensitive. Laser thermal contrast had 92% accuracy (R = 0.91, p<0.001) in quantifying CRAG titers from 1 LFA strip to within <1.5 dilutions of actual CRAG titers. CRAG LFA is a major advance for meningitis diagnostics in resource-limited settings.

1 August 2019 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
JRJoshua Rhein
Joshua Rhein
KHKathy Huppler Hullsiek
Kathy Huppler Hullsiek
LTLillian Tugume
Lillian Tugume
ENEdwin Nuwagira
Edwin Nuwagira
EMEdward Mpoza
Edward Mpoza
KNKirsten Nielsen
Kirsten Nielsen

1 April 2015 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
DWDarlisha A. Williams
Darlisha A. Williams
TKTadeo Kiiza
Tadeo Kiiza
RKRichard Kwizera
Richard Kwizera
RKReuben Kiggundu
Reuben Kiggundu
SVSruti Velamakanni
Sruti Velamakanni
DBDavid Boulware
David Boulware
Background. Cryptococcus neoformans is the most common cause of adult meningitis in sub-Saharan Africa. The cryptococcal antigen (CRAG) lateral flow assay (LFA) has simplified diagnosis as a point-of-care test approved for serum or cerebrospinal fluid (CSF). We evaluated the accuracy of the CRAG LFA using fingerstick whole blood compared with serum/plasma and CSF for diagnosing meningitis. Methods. From August 2013 to August 2014, CRAG LFA (IMMY, Norman, Oklahoma) tests were performed on fingerstick whole blood, plasma/serum, and CSF in 207 HIV-infected adults with suspected meningitis in Kampala, Uganda. Venous blood was also collected and centrifuged to obtain serum and/or plasma. CSF was tested after lumbar puncture. Results. Of 207 participants, 149 (72%) had fingerstick CRAG-positive results. There was 100% agreement between fingerstick whole blood and serum/plasma. Of the 149 fingerstick CRAG-positive participants, 138 (93%) had evidence of cryptococcal meningitis with a positive CSF CRAG. Eleven participants (5%) had isolated cryptococcal antigenemia with a negative CSF CRAG and culture, of whom 8 had CSF abnormalities (n = 3 lymphocytic pleocytosis, n = 5 elevated protein, n = 4 increased opening pressure). No persons with cryptococcal meningitis had negative fingersticks. Conclusions. The 100% agreement between whole blood, serum, and plasma CRAG LFA results demonstrates that fingerstick CRAG is a reliable bedside diagnostic test. Using point-of-care CRAG testing simplifies screening large numbers of patients and enables physicians to prioritize on whom to measure CSF opening pressure using manometers.

6 December 2019 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
RKRichard Kwizera
Richard Kwizera
AKAndrew Katende
Andrew Katende
ATAnneth Teu
Anneth Teu
DADenise Apolot
Denise Apolot
WWWilliam Worodria
William Worodria
Felix BognominFelix Bognomin
Felix Bognomin

2 June 2020 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
Felix BognominFelix Bognomin
Felix Bognomin
LALucy Grace Asio
Lucy Grace Asio
JBJoseph Baruch Baluku
Joseph Baruch Baluku
RKRichard Kwizera
Richard Kwizera
DDDavid W. Denning
David W. Denning
Chronic pulmonary aspergillosis (CPA) is a spectrum of several progressive disease manifestations caused by Aspergillus species in patients with underlying structural lung diseases. Duration of symptoms longer than three months distinguishes CPA from acute and subacute invasive pulmonary aspergillosis. CPA affects over 3 million individuals worldwide. Its diagnostic approach requires a thorough Clinical, Radiological, Immunological and Mycological (CRIM) assessment. The diagnosis of CPA requires (1) demonstration of one or more cavities with or without a fungal ball present or nodules on chest imaging, (2) direct evidence of Aspergillus infection or an immunological response to Aspergillus species and (3) exclusion of alternative diagnoses, although CPA and mycobacterial disease can be synchronous. Aspergillus antibody is elevated in over 90% of patients and is the cornerstone for CPA diagnosis. Long-term oral antifungal therapy improves quality of life, arrests haemoptysis and prevents disease progression. Itraconazole and voriconazole are alternative first-line agents; voriconazole is preferred for patients with contra-indications to itraconazole and in those with severe disease (including large aspergilloma). In patients co-infected with tuberculosis (TB), it is not possible to treat TB with rifampicin and concurrently administer azoles, because of profound drug interactions. In those with pan-azole resistance or intolerance or progressive disease while on oral triazoles, short-term courses of intravenous liposomal amphotericin B or micafungin is used. Surgery benefits patients with well-circumscribed simple aspergillomas and should be offered earlier in low-resource settings.

12 May 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
ATAlexander Y. Trick
Alexander Y. Trick
JMJohan H. Melendez
Johan H. Melendez
FCFan-En Chen
Fan-En Chen
LCLiben Chen
Liben Chen
AOAnnet Onzia
Annet Onzia
TWTza-Huei Wang
Tza-Huei Wang
A portable magnetofluidic platform integrates nucleic acid purification and PCR to rapidly detect the pathogen causing gonorrhea in clinical samples.